{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:58:42Z","timestamp":1773086322594,"version":"3.50.1"},"reference-count":28,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The use of saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sparks debate due to presumed lower sensitivity and lack of standardization. Our aim was to evaluate the performance characteristics of (i) saliva collected by the ORAcollectTM device as a matrix for SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR), and (ii) 2 saliva rapid antigen tests (AgRDT). From 342 ambulatory individuals, both a nasopharyngeal swab and saliva sample via ORAcollectTM were obtained for a SARS-CoV-2 RT-PCR test. Furthermore, 54 and 123 additionally performed the V-ChekTM or WhistlingTM saliva AgRDT. In total, 35% of individuals screened positive for SARS-CoV-2 via nasopharyngeal swab. Saliva, as a matrix for the RT-PCR, had a specificity of 96.5% and a negative predictive value (NPV) of 91.3%. Interestingly, 6 out of 8 patients thought to be false positive in saliva re-tested positive by nasopharyngeal sampling after 2 to 9 days. Both V-ChekTM and WhistlingTM AgRDT had a lack of sensitivity, resulting in an NPV of 66.9 and 67.3%, respectively. Saliva proved to be a sensitive and specific matrix for SARS-CoV-2 detection by the RT-PCR. In this setting, saliva might have an earlier window of detection than the nasopharyngeal swab. By contrast, both AgRDT showed an unacceptably low sensitivity and NPV.<\/jats:p>","DOI":"10.3390\/v14091931","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T02:09:36Z","timestamp":1661911776000},"page":"1931","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of Saliva as a Matrix for RT-PCR Analysis and Two Rapid Antigen Tests for the Detection of SARS-CoV-2"],"prefix":"10.3390","volume":"14","author":[{"given":"Julie","family":"De Meyer","sequence":"first","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Goris","sequence":"additional","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Mortel\u00e9","sequence":"additional","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Spiessens","sequence":"additional","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4522-9055","authenticated-orcid":false,"given":"Guy","family":"Hans","sequence":"additional","affiliation":[{"name":"Mobile Testing Team, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Jansens","sequence":"additional","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2137-2068","authenticated-orcid":false,"given":"Veerle","family":"Matheeussen","sequence":"additional","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-9584","authenticated-orcid":false,"given":"Sarah","family":"Vandamme","sequence":"additional","affiliation":[{"name":"Department Microbiology, Laboratory Medicine, Antwerp University Hospital (UZA), 2650 Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_2","unstructured":"World Health Organization (2020). Novel Coronavirus (2019-nCoV), World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41746-020-0260-4","article-title":"Verification, analytical validation, and clinical validation (V3): The foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)","volume":"3","author":"Goldsack","year":"2020","journal-title":"NPJ Digit. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"114381","DOI":"10.1016\/j.jviromet.2021.114381","article-title":"The evolving direct and indirect platforms for the detection of SARS-CoV-2","volume":"300","author":"Shahgolzari","year":"2022","journal-title":"J. Virol. Methods"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Khalid, M.F., Selvam, K., Jeffry, A.J.N., Salmi, M.F., Najib, M.A., Norhayati, M.N., and Aziah, I. (2022). Performance of Rapid Antigen Tests for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12010110"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMc2016359","article-title":"Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2","volume":"383","author":"Wyllie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_7","unstructured":"European Centre for Disease Prevention and Control (2021). Options for the Use of Rapid Antigen Detection Tests for COVID-19 in the EU\/EEA\u2014First Update, European Centre for Disease Prevention and Control."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jmoldx.2021.07.017","article-title":"Evaluating Diagnostic Accuracy of Saliva Sampling Methods for Severe Acute Respiratory Syndrome Coronavirus 2 Reveals Differential Sensitivity and Association with Viral Load","volume":"23","author":"Mestdagh","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Marais, G., Hsiao, N.-y., Iranzadeh, A., Doolabh, D., Enoch, A., Chu, C.-y., Williamson, C., Brink, A., and Hardie, D. (2021). Saliva swabs are the preferred sample for Omicron detection. medRxiv.","DOI":"10.1101\/2021.12.22.21268246"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.36557\/2674-8169.2022v4n1p50-54","article-title":"HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung","volume":"4","author":"Chan","year":"2022","journal-title":"Braz. J. Implantol. Health Sci."},{"key":"ref_11","unstructured":"World Health Organization (2021). Recommendations for National SARS-CoV-2 Testing Strategies and Diagnostic Capacities, World Health Organization."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A Coefficient of Agreement for Nominal Scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"778790","DOI":"10.3389\/fviro.2021.778790","article-title":"Saliva for COVID-19 Testing: Simple but Useless or an Undervalued Resource?","volume":"1","author":"Tarantini","year":"2021","journal-title":"Front. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kritikos, A., Caruana, G., Brouillet, R., Miroz, J.-P., Abed-Maillard, S., Stieger, G., Opota, O., Croxatto, A., Vollenweider, P., and Bart, P.-A. (2021). Sensitivity of Rapid Antigen Testing and RT-PCR Performed on Nasopharyngeal Swabs versus Saliva Samples in COVID-19 Hospitalized Patients: Results of a Prospective Comparative Trial (RESTART). Microorganisms, 9.","DOI":"10.1101\/2021.04.09.21255105"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Caruana, G., Croxatto, A., Kampouri, E., Kritikos, A., Opota, O., Foerster, M., Brouillet, R., Senn, L., Lienhard, R., and Egli, A. (2021). Implementing SARS-CoV-2 Rapid Antigen Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study. Microorganisms, 9.","DOI":"10.1101\/2021.02.10.21250915"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_17","unstructured":"U.S. Food and Drug Administration (2020). Emergency use authorization (EUA) summary ORAcollect, RNA Device Models (ORAcollect\u00b7RNA ORE-100 and ORACOLLECT\u00b7RNA or-100)."},{"key":"ref_18","unstructured":"De Meyer, J., Goris, H., Mortel\u00e9, O., Spiessens, A., Hans, G., Jansens, H., Goossens, H., Matheeussen, V., and Vandamme, S. (2022). Effect of ORAcollectTM extraction volume on the \u0394Ct between saliva and nasopharyngeal swab SARS-CoV-2 RT-PCR results, Unpublished work."},{"key":"ref_19","unstructured":"De Meyer, J., Goris, H., Mortel\u00e9, O., Spiessens, A., Hans, G., Jansens, H., Goossens, H., Matheeussen, V., and Vandamme, S. (2022). Detection of RNAseP in discordant saliva samples, Unpublished work."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijid.2022.03.037","article-title":"Diagnostic accuracy of SARS-CoV-2 saliva antigen testing in a real-life clinical setting","volume":"119","author":"Jegerlehner","year":"2022","journal-title":"International J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"285.e1","DOI":"10.1016\/j.cmi.2020.05.001","article-title":"Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: A cross-sectional study","volume":"27","author":"Pasomsub","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Doba\u00f1o, C., Alonso, S., Vidal, M., Jim\u00e9nez, A., Rubio, R., Santano, R., Barrios, D., Tomas, G.P., Mel\u00e9 Casas, M., and Hern\u00e1ndez Garc\u00eda, M. (2021). Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum from Infected Children and their Close Contacts. medRxiv.","DOI":"10.1101\/2021.03.22.21254120"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Igloi, Z., Velzing, J., Huisman, R., Geurtsvankessel, C., Comvalius, A., Ijpelaar, J., van Beek, J., Ensing, R., Boelsums, T., and Koopmans, M. (2021). Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260894"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Platten, M., Hoffmann, D., Grosser, R., Wisplinghoff, F., Wisplinghoff, H., Wiesmuller, G., Schildgen, O., and Schildgen, V. (2021). SARS-CoV-2, CT-Values, and Infectivity-Conclusions to Be Drawn from Side Observations. Viruses, 13.","DOI":"10.3390\/v13081459"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.2021.13967","article-title":"Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection","volume":"326","author":"Lee","year":"2021","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jiac.2020.06.011","article-title":"A case report of SARS-CoV-2 confirmed in saliva specimens up to 37 days after onset: Proposal of saliva specimens for COVID-19 diagnosis and virus monitoring","volume":"26","author":"Tajima","year":"2020","journal-title":"J. Infect. Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1080\/22221751.2020.1775133","article-title":"Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg. Microbes Infect."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/9\/1931\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:20:39Z","timestamp":1760142039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/9\/1931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["v14091931"],"URL":"https:\/\/doi.org\/10.3390\/v14091931","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]}}}